Tectonic Therapeutic (TECX) Net Cash Flow (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Net Cash Flow of -$17.6 million for Q1 2026, down 110.66% year-over-year from $165.0 million in Q1 2025, and down 20.43% quarter-over-quarter from -$14.6 million in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Net Cash Flow (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Net Cash Flow for 10 consecutive years, with -$17.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 110.66% year-over-year to -$17.6 million; the TTM figure through Mar 2026 stood at -$69.5 million (down 124.16% YoY), while the FY2025 annual figure was $113.1 million, up 0.59% from the prior year.
- Net Cash Flow fell to -$17.6 million in Q1 2026 per TECX's latest filing, from -$14.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $166.4 million in Q2 2024 and bottomed at -$29.3 million in Q2 2022.
- Historically, Net Cash Flow has averaged $6.1 million across 5 years, with a median of -$17.6 million in 2026.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 343.98% — and 2024, when it jumped 20973.27%.
- Tectonic Therapeutic's Net Cash Flow stood at -$23.6 million in 2022, then soared by 194.96% to $22.4 million in 2023, then slumped by 179.8% to -$17.9 million in 2024, then gained by 18.39% to -$14.6 million in 2025, then declined by 20.43% to -$17.6 million in 2026.
- Business Quant data shows TECX's Net Cash Flow at -$17.6 million in Q1 2026, -$14.6 million in Q4 2025, and -$18.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | -9.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.83 Mn |
| Mar 31, 2026 | -17.59 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | -18.44 Mn |
| Jun 30, 2025 | -18.83 Mn |
| Mar 31, 2025 | 165.01 Mn |
| Dec 31, 2024 | -17.89 Mn |
| Sep 30, 2024 | -26.04 Mn |
| Jun 30, 2024 | 166.36 Mn |
| Mar 31, 2024 | -9.95 Mn |
| Dec 31, 2023 | 22.42 Mn |
| Sep 30, 2023 | -8.60 Mn |
| Jun 30, 2023 | -797,000.00 |
| Mar 31, 2023 | -20.24 Mn |
| Dec 31, 2022 | -23.61 Mn |
| Sep 30, 2022 | -16.44 Mn |
| Jun 30, 2022 | -29.25 Mn |
| Mar 31, 2022 | -27.90 Mn |
| Dec 31, 2021 | -11.80 Mn |
| Sep 30, 2021 | -25.07 Mn |